Skip to main content
. 2014 Nov 19;3(2):415–419. doi: 10.3892/mco.2014.457

Table II.

Response to bevacizumab - containing treatment.

Tumour response (n o.)a

Response of pleural effusion (no.)b Partial response Stable disease Progressive disease
Complete response (n=7) 3 3 1
Partial response (n=8) 0 7 1
No response (n=6) 2 3 1
Total (n=21) 5 13 3
a

Tumour response rate, 23.8%.

b

Response rate of pleural effusion, 71.4%.